Combining tubercidin and cordycepin scaffolds results in highly active candidates to treat late-stage sleeping sickness
Trypanosoma brucei relies on uptake and conversion of purines from the host, which constitutes a potential drug target. Here, Hulpia et al. combine structural elements from known trypanocidal nucleoside analogues and develop a potent trypanocide with curative activity in animal models of acute and l...
Guardado en:
Autores principales: | Fabian Hulpia, Dorien Mabille, Gustavo D. Campagnaro, Gabriela Schumann, Louis Maes, Isabel Roditi, Anders Hofer, Harry P. de Koning, Guy Caljon, Serge Van Calenbergh |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ac12d894b82c4ecab2670dd0dcf7314e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Metabolic impacts of cordycepin on hepatic proteomic expression in streptozotocin-induced type 1 diabetic mice.
por: Kongphop Parunyakul, et al.
Publicado: (2021) -
Cordycepin prevents radiation ulcer by inhibiting cell senescence via NRF2 and AMPK in rodents
por: Ziwen Wang, et al.
Publicado: (2019) -
In Sickness and in Health
por: Amy Waterson
Publicado: (2021) -
Cordycepin Nanoencapsulated in Poly(Lactic-Co-Glycolic Acid) Exhibits Better Cytotoxicity and Lower Hemotoxicity Than Free Drug
por: Marslin G, et al.
Publicado: (2020) -
Sick Surgeon: Problem and the panacea!
por: Bikal Ghimire
Publicado: (2018)